Midas Letter and C-Suite are excited to announce Midas Letter LIVE. Midas Letter highlights the stocks and stories to watch in the Canadian markets today. Host James West is a recognized authority on investing in the emerging company segment having been a regularly featured guest on Business News Network, CNBC, Bloomberg, Reuters, and CTV. James West and guests provide comprehensive fundamental & technical analysis on all trending business and investment news, while interviewing the top CEOs of all public companies and analysts with the highest reputations in the business. Midas Letter is excited to feature all investing content on C-suite.
BlissCo Cannabis Corp (CNSX:BLIS) Earns Positive EU GMP Evaluation
BlissCo Cannabis Corp (CNSX:BLIS) (OTCMKTS:HSTRF) (FRA:GQ4B) CEO Damian Kettlewell shares samples of the company’s recyclable packaging made from materials such as milk jugs and ocean waste. Kettlewell explains that the company receives its dried flower license in November and is currently selling dried flower and prerolls. BlissCo expects to be selling a high CBD cannabis oil, a balanced CBD/THC oil product, and a high THC oil in the summer. BlissCo has a supply agreement with Supreme Cannabis Company Inc (TSE:FIRE) (OTCMKTS:SPRWF) (FRA:53S1), which also has a minority stake in BlissCo. Kettlewell highlights that by producing its own brands, BlissCo differs from other leading extractors in the space, such as MediPharm Labs Corp (CVE:LABS) (OTCMKTS:MEDIF) (FRA:MLZ) and Valens GroWorks Corp (CNSX:VGW) (OTCMKTS:VGWCF) (FRA:7LV). Kettlewell explains the process of certifying BlissCo production facilities as EU GMP compliant and shares details of a recent positive inspection conducted by EU officials at the company’s site.